Panelists will discuss the short and longer-term impact of digital patient engagement on cancer care. They will describe how digital solutions (remote monitoring, telemedicine, data collection, etc.) have improved patient outcomes and enabled new care models, patient experience and scientific insights.
Jani Ahonala is the global head of patient outcomes at Varian, where he spearheads the strategy for Noona, the company’s smart cloud-based mobile service designed to capture patient-reported outcomes (PROs) in oncology. Ahonala focuses on Varian’s global go-to-market strategies for Noona in addition to business development, brand management, thought leadership, partnership, and stakeholder integration. Ahonala has worked in the field of cancer treatment throughout his career, 15 years of which involved experience as an entrepreneur, healthcare management consultant, and researcher. He had the opportunity to observe first-hand how much anticipatory symptoms monitoring can improve patients’ quality of life, all while positively impacting healthcare costs. His current role at Varian is at the intersection of technology, design and medical expertise, as he guides the team to work with the world’s leading cancer researchers and foremost clinics, including Stanford University. He holds a master’s degree in economic sciences from the University of Vaasa.
Bonnie J. Addario, Co-Founder and Board Chair of GO2 Foundation for Lung Cancer (GO2 Foundation) is an advocate and educator empowering patients and giving them a voice since receiving a stage 3B lung cancer diagnosis more than a decade ago. Recognizing the need for education, empowerment, advocacy and research to help patients and families, Bonnie and her family founded the Bonnie J. Addario Lung Cancer Foundation (ALCF) in 2006. In 2019, ALCF and Lung Cancer Alliance joined forces to become GO2 Foundation for Lung Cancer. Bonnie acts as an adviser to patients, industry leaders, clinicians and policy makers and is a member of the Personalized Medicine Coalition board.
Jeff Patton is a board-certified hematologist and oncologist, Chief Executive Officer and Board Member at OneOncology, where he also served as President of Physician Services for over a year. His primary mission is to improve the lives of everyone living with cancer. Dr. Patton is leading OneOncology in growing their advanced partnership of top community oncology practices and positioning them to support the entire continuum of cancer care in any reimbursement environment.Dr. Patton practiced with Tennessee Oncology, one of the nations leading oncology practices, for 24 years. He is currently the Executive Chairman of the Board and served as CEO of Tennessee Oncology for a decade (2010-2020). Dr. Patton is also an active member of the American Society of Clinical Oncology (ASCO), Tennessee Oncology Practice Society (TOPS), and serves as Chairman of the Community Oncology Alliance (COA).